Skip to main content
. 2008 Apr 1;2:209–219. doi: 10.4137/cmo.s548

Figure 2. Tumors found in Dmp1-deficient mice.

Figure 2

A: mandibular carcinosarcoma (Dmp1−/−, untreated, 76 weeks); B: T-cell leukemia/lymphoma (Dmp1+/−, untreated, 48 weeks); C: lung adenocarcinoma (Dmp1−/−, untreated, 86 weeks); D: ovarian granulose cell tumor (Dmp1−/−, DMBA-treated, 26 weeks); E: hepatocellular carcinoma (Dmp1+/−, irradiated, 61 weeks); and F: malignant melanoma (Dmp1−/−, DMBA-treated, 39 weeks). These tumors were not observed in the Dmp1+/+ littermate controls of the same age (Inoue et al. 2000, 2001).